Market Notice
The security Sangamo Therapeutics Inc. Registered Shares DL -,01 with ISIN US8006771062 is currently suspended from trading. Please note that existing orders in this security have been cancelled. Orders can be placed again once trading is resumed.
Sangamo Therapeutics Inc. Registered Shares DL -,01
Sector and Industry
Healthcare, Healthcare Services
Performance (1Y)
83.14%
Market Cap
277.32 Mil.
P/E Ratio
0.00
Dividend Yield
0.00 %
Earnings per Share
-0.39 €
Peer Group
| Company Name | Market Cap | Revenue Last Reported Year | P/E Ratio | Profit Growth 1Y | Last Price | Previous Trading Day Change |
|---|---|---|---|---|---|---|
| UnitedHealth Group Inc. | 254.66 Bil. | 396.73 Bil. | 24.94 | -19.75 % | 0.00 | - |
| Thermo Fisher Scientific Inc. | 185.62 Bil. | 39.50 Bil. | 32.67 | +1.45 % | 0.00 | - |
| Danaher Corp. | 137.79 Bil. | 21.78 Bil. | 45.36 | -11.47 % | 0.00 | - |
| McKesson Corporation | 90.13 Bil. | 348.09 Bil. | 22.55 | +33.83 % | 0.00 | - |
| HCA Healthcare Inc. | 89.28 Bil. | 67.01 Bil. | 16.48 | +12.93 % | 0.00 | - |
| Elevance Health Inc. | 65.88 Bil. | 176.51 Bil. | 13.91 | -9.22 % | 0.00 | - |
| The Cigna Group | 61.74 Bil. | 243.65 Bil. | 12.41 | +66.33 % | 0.00 | - |
| Cencora Inc. | 51.58 Bil. | 291.15 Bil. | 39.26 | +1.16 % | 0.00 | - |
| IDEXX Laboratories Inc. | 45.92 Bil. | 3.81 Bil. | 51.74 | +14.41 % | 0.00 | - |
| Zoetis Inc. | 45.52 Bil. | 8.39 Bil. | 20.89 | +3.10 % | 0.00 | - |
Facts & figures
Price data
| TRADE PLATFORM | Börse Stuttgart (XSTU) | |
| LAST PRICE | 0.11 G | 0 Units |
| PRICE DETERMINATION TIME | 05/08/2026 / 09:55:04 PM | |
| DAILY VOLUME (UNITS) | 640 | |
| DAILY HIGH / LOW | 0.11 | 0.08 |
| PREV. DAY'S PRICE | 0.08 | (05/07) |
| CHANGE DAY BEFORE | +0.03 | 37.50 % |
| 52 WEEK HIGH / LOW | 0.6685 (05/12) | 0.063 (04/29) |
Key Figures (in EUR)
| 2027e | 2026e | 2025 | 2024 | 2023 | |
|---|---|---|---|---|---|
| EARNINGS PER SHARE | -0.09 | -0.23 | -0.39 | -0.45 | -1.37 |
| DIVIDENDS PER SHARE | - | - | 0.00 | 0.00 | 0.00 |
| DIVIDEND YIELD IN % | - | - | 0.00 % | 0.00 % | 0.00 % |
| DIVIDEND GROWTH IN % | - | - | - | - | - |
| PRICE - EARNINGS RATIO | - | - | - | - | - |
| PRICE - BOOK RATIO | - | - | - | 9.53 | 1.17 |
| PRICE - SALES RATIO | - | - | 2.98 | 3.56 | 0.54 |
| PRICE - CASH FLOW RATIO | - | - | - | - | - |
Master Data
| WKN | 936386 |
| ISIN | US8006771062 |
| SYMBOL | GBY |
| EXCHANGE SEGMENT | Freiverkehr |
| TYPE OF FINANCIAL INSTRUMENT | Equity |
| DENOMINATION | Sangamo Biosciences |
| INDEX MEMBERSHIP | - |
| TRADING SEGMENT | - |
| TRADING HOURS | 07:30:00 AM - 10:00:00 PM |
| TRADING CURRENCY | Euro |
| NOMINAL CURRENCY | US Dollar |
| SETTLEMENT CURRENCY | Euro |
| SECTOR AND INDUSTRY | Healthcare, Healthcare Services |
| NUMBER OF SHARES | 178.91 Mil. |
| MARKET CAPITALISATION | 277.32 Mil. |
Performance overview
| 1W | 1M | 3M | 6M | 1Y | 3Y | 5Y | YTD | |
|---|---|---|---|---|---|---|---|---|
| PERFORMANCE | 7.74 % | -48.84 % | -66.59 % | -71.88 % | -83.14 % | -90.43 % | -98.73 % | -68.13 % |
| HIGH | 0.17 | 0.24 | 0.45 | 0.50 | 0.67 | 3.00 | 10.66 | 0.50 |
| LOW | 0.08 | 0.06 | 0.06 | 0.06 | 0.06 | 0.06 | 0.06 | 0.06 |
Dividend
per share
Sangamo Biosciences does not deliver dividend information
Company profile
Sangamo Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the research and development of zinc finger proteins. The firm focuses on three therapeutic areas: inherited metabolic diseases, central nervous system, and diseases and immunology, which consist of inflammatory and autoimmune diseases. It also offers complementary technology platforms such as gene therapy, ex vivo cell therapy, in vivo genome editing, and in vivo genome regulation. The company was founded by Edward O. Lanphier II in 1995 and is headquartered in Richmond, CA.
Analyst Rating
Ø-Target Price DistanceNot Available
Current Price
Not AvailableØ-Target Price
Not AvailableAverage ResultNot Available
Buy0
Overweight0
Hold0
Underweight 0
Sell0
Company Events
No company events available.